文献速递消化道肿瘤与早癌

血清25-羟基维生素D水平与结直肠癌风险:按年龄分层的分析

Serum 25-Hydroxyvitamin D Levels and Risk of Colorectal Cancer: An Age-Stratified Analysis.
PubMed 文献 · Gastroenterology · 2023-07-08

这项韩国成年人队列研究纳入236,382名接受健康体检并检测血清25(OH)D的参与者,按年龄(<50岁 vs ≥50岁)分层分析25(OH)D水平与结直肠癌发病风险的关系。中位随访6.5年期间341人发生结直肠癌;<50岁人群中25(OH)D 10-19 ng/mL和≥20 ng/mL相对于<10 ng/mL的HR分别为0.61和0.41。≥50岁人群关联相似但略有减弱。

要点

  • 血清25(OH)D水平与<50岁人群结直肠癌风险呈负相关,趋势检验P<.001。
  • 25(OH)D 10-19 ng/mL者HR 0.61(95%CI 0.43-0.86),≥20 ng/mL者HR 0.41(95%CI 0.27-0.63)。
  • ≥50岁人群关联方向相似但较年轻人群略有减弱。

核心结论

  • 血清25(OH)D水平可能与早发型和晚发型结直肠癌的发病风险均存在有益关联。

研究设计与样本

  • 队列研究,纳入236,382名接受综合健康体检(含血清25(OH)D检测)的韩国成年人,平均年龄38.0岁(标准差9.0)。
  • 血清25(OH)D水平分为<10、10-20、≥20 ng/mL三组,通过国家癌症登记系统确认结直肠癌及其组织学亚型、部位和侵袭性。
  • 采用Cox比例风险模型估计风险比(HR)及95%置信区间(CI),并校正潜在混杂因素。
  • 随访共1,393,741人年,中位随访6.5年(四分位距4.5-7.5年)。

主要发现

  • 随访期间341人发生结直肠癌,发病率为19.2/10^5人年。
  • <50岁人群中,相对于25(OH)D<10 ng/mL,10-19 ng/mL组结直肠癌发病HR为0.61(95%CI 0.43-0.86),≥20 ng/mL组HR为0.41(95%CI 0.27-0.63)(趋势检验P<.001,时间依赖模型)。
  • <50岁人群中,腺癌、结肠癌和侵袭性癌均可见显著关联。
  • ≥50岁人群中关联相似,但较年轻人群略有减弱。

关键数值与推荐

  • 血清25(OH)D分组界值:<10、10-20、≥20 ng/mL。
  • <50岁人群25(OH)D 10-19 ng/mL vs <10 ng/mL的HR为0.61(95%CI 0.43-0.86)。
  • <50岁人群25(OH)D≥20 ng/mL vs <10 ng/mL的HR为0.41(95%CI 0.27-0.63)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The role of circulating 25-hydroxyvitamin D (25(OH)D) in the prevention of early-onset colorectal cancer (CRC) in young adults aged <50 years is uncertain. We evaluated the age-stratified associations (<50 vs ≥50 years) between circulating 25(OH)D levels and the risk of CRC in a large sample of Korean adults. METHODS: Our cohort study included 236,382 participants (mean age, 38.0 [standard deviation, 9.0] years) who underwent a comprehensive health examination, including measurement of serum 25(OH)D levels. Serum 25(OH)D levels were categorized as <10, 10 to 20, and ≥20 ng/mL. CRC, along with the histologic subtype, site, and invasiveness, was ascertained through linkage with the national cancer registry. Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CRC according to the serum 25(OH)D status, with adjustment for potential confounders. RESULTS: During the 1,393,741 person-years of follow-up (median, 6.5 years; interquartile range, 4.5-7.5 years), 341 participants developed CRC (incidence rate, 19.2 per 105 person-years). Among young individuals aged <50 years, serum 25(OH)D levels were inversely associated with the risk of incident CRC with HRs (95% CIs) of 0.61 (0.43-0.86) and 0.41 (0.27-0.63) for 25(OH)D 10 to 19 ng/mL and ≥20 ng/mL, respectively, with respect to the reference (<10 ng/mL) (P for trend <.001, time-dependent model). Significant associations were evident for adenocarcinoma, colon cancer, and invasive cancers. For those aged ≥50 years, associations were similar, although slightly attenuated compared with younger individuals. CONCLUSIONS: Serum 25(OH)D levels may have beneficial associations with the risk of developing CRC for both early-onset and late-onset disease.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kim Y, Chang Y, Cho Y, et al. Serum 25-Hydroxyvitamin D Levels and Risk of Colorectal Cancer: An Age-Stratified Analysis. Gastroenterology. 2023. PMID: 37429364. doi:10.1053/j.gastro.2023.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。